menaquinone-7Finding
Menaquinone‑7 decreases Plasma desphospho-uncarboxylated matrix Gla protein (dp-ucMGP)
lowersModerate evidenceFindingreplicated ×1
01 · The sentence it was drawn from
“Dp‐ucMGP levels were significantly lower, however, in the 200 μg and 400 μg vitamin K2 groups than in the placebo group, confirming that vitamin K was producing the expected dose‐dependent effect on this marker of vitamin K biological activity.”
menaquinone-7
Plasma desphospho- uncarboxylated matrix Gla protein (dp-ucMGP)
lowers
- Who
- community-dwelling adults aged 65 and older with two or more falls, or one fall leading to hospitalisation, in the previous year, recruited through primary care in Tayside, Grampian and Fife, Scotland; 200 µg and 400 µg arms each compared with placebo
- Dose studied
- vitamin K2 as MK-7, 200 µg or 400 µg, one tablet daily for 12 months
Moderate evidencePMID 31211416 · 2019
02 · The study
- Study
- RCT
- Duration
- 12 months
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Journal of the American Geriatrics Society04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7GJWSX95QKMTHKMK341S6BQ